PolyPid Ltd. Provides Corporate Update and Reports Second Quarter 2020 Financial Results

Initiated Phase 3 SHIELD I Trial for D-PLEX 100 in Abdominal Surgery and Received Fast Track Designation for D-PLEX 100 from FDA Presented Positive Phase 2 Results of D-PLEX 100 for Prevention of Surgical Site Infections in Abdominal Surgery at ASCRS Meeting Completed Initial Public Offering in